Patent ID: 11858937
Assignee: QURIENT CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A compound having Formula I:, or a pharmaceutically acceptable salt or stereoisomer thereof,
wherein:
X is CH or N;
R1 is H;
R2 is C1-C6 alkyl, C1-C3 haloalkyl, or C(O)CH3;
Q is —C(O)—, —C(O)CH2—, —C(O)NH—, —NH—, —NHCH2—, —NHCH2CH2—, —NHC(O)—, —NHS(O)2—, —O—, or —OCH2—;
Y is C1-C6 alkyl, C3-C6 cycloalkyl, heterocyclyl, aryl, or heteroaryl;
wherein the C1-C6 alkyl is substituted with one or two substituents independently selected from the group consisting of NR5R5, OR5, heterocyclyl, aryl, and heteroaryl;
wherein the C3-C8 cycloalkyl or heterocyclyl is optionally substituted with one or two substituents independently selected from the group consisting of R3, R4, and C(O)R5; and
wherein the aryl or heteroaryl is optionally substituted with one or two substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C(O)R5, NR5R5, OR5, heterocyclyl, heteroaryl, and R3;

each R3 is independently H, halogen, C1-C6 alkyl, C(O)NH2, NR5R5, NHC(O)R5, OR5, heterocyclyl, aryl, or heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH;
each R4 is independently H, halogen, C1-C6 alkyl, NR5R5, OR5, ═O, heterocyclyl, aryl, or heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH;
each R5 is independently H, C1-C6 alkyl, C1-C3 haloalkyl, C3-C6 cycloalkyl, heterocyclyl, or heteroaryl;
wherein each heterocyclyl and heteroaryl is optionally and independently substituted with one or two substituents independently selected from the group consisting of halogen, C1-C6 alkyl, NR11R11, and OR11; and
wherein each C1-C6 alkyl substituent of each heterocyclyl and heteroaryl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH;

each R11 is independently H, C1-C6 alkyl, C3-C10 cycloalkyl, or W;
Z is:, (i) R6 is a ring selected from the following Group B:, R12 is H;
R16 is W;
R17 is H, C1-C6 alkyl, or C1-C3 haloalkyl;
R18 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, NH2, or Ole; and
is 1, 2, or 3; or

(ii) R6 is a ring selected from the following Group B:, R12 is W;
R16 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, NH2, or OW;
R17 is H, C1-C6 alkyl, or C1-C3 haloalkyl;
R18 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, NH2, or OW; and
is 1, 2, or 3; or

(iii) R6 is a ring selected from the following Group B:, and
R15 is W; or

(iv) R6 is a ring selected from the following Group B:, and
R15 is H; and
R19 is W; or

(v) R6 is a ring selected from the following Group B:, R7 is H;
R8 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, or OR5, wherein the C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of NHR5 and OR5;
R9 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, or OR5, wherein the C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of NHR5 and OR5;
R10 is H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, or OR5, wherein the C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of NHR5 and OR5;
W is a structure selected from the following Group C:, each L is independently absent, —NH—, or —O—;
each R20 is independently H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, OR5, or heterocyclyl;
each R21 is independently H, halogen, CN, C1-C6 alkyl, C1-C3 haloalkyl, OR5, or heterocyclyl;
each R22 is independently H, halogen, CN, C1-C6 alkyl, NR5R5, NR19R20, NR19CH2C(O)NH2, OR5, C3-C10 cycloalkyl, or heterocyclyl, wherein each R19 is independently H, C1-C6 alkyl, C3-C10 cycloalkyl, or W; and
each n is independently 1, 2, or 3.